兰州大学机构库
National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020
2023-02
Online publication date2023-05
Source PublicationLANCET REGIONAL HEALTH-WESTERN PACIFIC   Impact Factor & Quartile
ISSN2666-6065
Volume34
page numbers13
AbstractBackground The lack of a well-designed brain tumour registry with standardized pathological diagnoses in underdeveloped countries hinders the ability to compare epidemiologic data across the globe. The National Brain Tumour Registry of China (NBTRC), created in January 2018, is the first multi-hospital-based brain tumour registry in China. Patient data reported to the NBTRC in years 2019-2020 were assessed.Methods Tumour pathology was based on the 2016 World Health Organization (WHO) classification of tumours of the central nervous system and ICD-O-3. The anatomical site was coded per the Surveillance, Epidemiology, and End Results (SEER) solid tumour module (version of July 2019). The cases were tabulated by histology and anatomical site. Categorical variables were reported as numbers (percentages). The distribution of tumours by age (0-14, 15-19, 20-39, 40-64, and 65+ years) was analysed.Findings There were a total of 25,537 brain tumours, foremost among them meningioma (23.63%), followed by tumours of the pituitary (23.42%), and nerve sheath tumours (9.09%). Glioblastoma, the most common and lethal form of primary brain cancer in adults, represented 8.56% of all cases. Of note, 6.48% of the malignant tumours were located in the brain stem. The percentage of malignant brain tumours decreased with increasing age, 24.08% in adults (40+ years), 30.25% in young adults (20-39 years), 35.27% in adolescents (15-19 years), and 49.83% in children (0-14 years). Among the 2107 paediatric patients, the most common sites were ventricle (17.19%), brainstem (14.03%), pituitary and craniopharyngeal duct (13.4%), and cerebellum (12.3%), a distribution that differed from that of the entire cohort. The histology distribution was also unique in children, with glioblastoma much less incident compared to the whole cohort (3% vs. 8.47%, p < 0.01). 58.80% of all patients chose higher-level neurosurgical hospitals outside of their province of residence. The median in-hospital length of stay (LOS) for the various pathologies ranged from 11 to 19 days.Interpretation The histological and anatomical site distribution of brain tumours in the NBTRC was statistically different in the subgroup of children (0-14 years). Patient choice of pursuing trans-provincial treatment was common and the in-hospital LOS was longer compared to that reported in similar European and American patient populations, which merits further attention.Funding The National Key Research and Development Program of China (2015BAI12B04, 2013BAI09B03, 2014BAI04B01, and 2021YFF1201104) and Chinese National Natural Science Foundation of China (81971668).Copyright & COPY; 2023 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
KeywordBrain tumor Registry Distribution China
PublisherELSEVIER
DOI10.1016/j.lanwpc.2023.100715
Indexed BySCIE ; SSCI
Language英语
WOS Research AreaHealth Care Sciences & Services ; Public, Environmental & Occupational Health
WOS SubjectHealth Care Sciences & Services ; Public, Environmental & Occupational Health
WOS IDWOS:001028034500001
Original Document TypeArticle
PMID 37283963
Citation statistics
Cited Times:1[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttps://ir.lzu.edu.cn/handle/262010/568505
Collection兰州大学
Corresponding AuthorZhang, Liwei
Affiliation
1.China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China;
2.Capital Med Univ, Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China;
3.Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China;
4.Beijing Neurosurg Inst, Beijing, Peoples R China;
5.Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou, Peoples R China;
6.Guangdong 999 Brain Hosp, Dept Neurosurg, Guangzhou, Peoples R China;
7.Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurosurg, Shenzhen, Peoples R China;
8.Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Neurosurg, Shenzhen, Peoples R China;
9.Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China;
10.Cent South Univ, Hunan Canc Hosp, Dept Neurosurg, Changsha, Peoples R China;
11.Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China;
12.China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Peoples R China;
13.Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Peoples R China;
14.Kunming Med Univ, Dept Neurosurg, Affiliated Hosp 1, Kunming, Peoples R China;
15.Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Peoples R China;
16.Shanxi Med Univ, Dept Neurosurg, Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China;
17.Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 1, Harbin, Peoples R China;
18.Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China;
19.Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China;
20.Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Peoples R China;
21.Ningxia Med Univ, Dept Neurosurg, Gen Hosp, Yinchuan, Peoples R China;
22.Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Peoples R China;
23.Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China;
24.Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China;
25.Cent South Univ, Dept Neurosurg, Xiangya Hosp, Changsha, Peoples R China;
26.Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Peoples R China;
27.Three Gorges Univ, Yichang Cent Peoples Hosp, Inst Neurosurg, Dept Neurosurg, Yichang, Peoples R China;
28.Three Gorges Univ, Clin Med Coll 1, Yichang, Peoples R China;
29.Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurosurg, Jinan, Peoples R China;
30.Shandong Univ, Inst Brain & Brain Inspired Sci, Cheeloo Coll Med, Jinan, Peoples R China;
31.Zhejiang Univ, Affiliated Hosp 1, Dept Neurosurg, Sch Med, Hangzhou, Peoples R China;
32.Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou, Peoples R China;
33.Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurosurg, Beijing, Peoples R China;
34.Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian, Peoples R China;
35.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Peoples R China;
36.Shanxi Med Univ, Hosp 1, Dept Neurosurg, Taiyuan, Peoples R China;
37.Chifeng Univ, Dept Neurosurg, Affiliated Hosp, Chifeng, Peoples R China;
38.Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China;
39.Xinjiang Med Univ, Dept Neurosurg, Affiliated Hosp 1, Urumqi, Peoples R China;
40.Inner Mongolia Med Univ, Dept Neurosurg, Affiliated Hosp, Hohhot, Peoples R China;
41.Guizhou Med Univ, Dept Neurosurg, Affiliated Hosp, Guiyang, Peoples R China;
42.Hainan Prov Peoples Hosp, Dept Neurosurg, Haikou, Peoples R China;
43.Nanjing Med Univ, Dept Neurosurg, Wuxi Peoples Hosp, Wuxi, Peoples R China;
44.Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Fuzhou, Peoples R China;
45.Soochow Univ, Dept Neurosurg, Affiliated Hosp 2, Suzhou, Peoples R China;
46.Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China;
47.Univ Chinese Acad Sci, Chongqing Hosp, Chongqing Gen Hosp, Dept Neurosurg, Chongqing, Peoples R China;
48.Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Neurosurg, Jinan, Peoples R China;
49.Cent South Univ, Dept Neurosurg, Xiangya Hosp 2, Changsha, Peoples R China;
50.Chengde Cent Hosp, Dept Neurosurg, Chengde, Peoples R China;
51.First Hosp Yulin, Dept Neurosurg, Yulin, Peoples R China;
52.First Hosp Jilin Univ, Dept Neurosurg, Changchun, Peoples R China;
53.Lanzhou Univ, Dept Neurosurg, Hosp 2, Lanzhou, Peoples R China;
54.Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 2, Hefei, Peoples R China;
55.Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Sch Basic Med,Dept Epidemiol & Stat, Beijing, Peoples R China;
56.Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX USA
Recommended Citation
GB/T 7714
Xiao, Dan,Yan, Changxiang,Li, Deling,et al. National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020[J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC,2023,34.
APA Xiao, Dan.,Yan, Changxiang.,Li, Deling.,Xi, Tianshu.,Liu, Xianzhi.,...&Zhang, Liwei.(2023).National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020.LANCET REGIONAL HEALTH-WESTERN PACIFIC,34.
MLA Xiao, Dan,et al."National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020".LANCET REGIONAL HEALTH-WESTERN PACIFIC 34(2023).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Xiao, Dan]'s Articles
[Yan, Changxiang]'s Articles
[Li, Deling]'s Articles
Baidu academic
Similar articles in Baidu academic
[Xiao, Dan]'s Articles
[Yan, Changxiang]'s Articles
[Li, Deling]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Xiao, Dan]'s Articles
[Yan, Changxiang]'s Articles
[Li, Deling]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.